Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Rick Veasey Added: 1 year ago
ESC Congress 24 — SHAM-PVI study finds pulmonary vein isolation effective in reducing atrial fibrillation (AF) episodes, improving quality of life.We are joined onsite by Dr Rick Veasey (Eastbourne District General Hospital, Eastbourne, UK) to discuss the findings from a SHAM-PVI, a randomized sham-controlled study of pulmonary vein isolation in symptomatic atrial fibrillation (NCT04272762; East… View more
Author(s): Boris Schmidt , Atul Verma Added: 3 months ago
AF Symposium 2026 - Repeat ablation strategies: Moving Beyond Pulmonary Vein Isolation and the Role of Advanced Mapping.Dr Boris Schmidt (Cardioangiologisches Centrum Bethanien, Frankfurt, DE) and Dr Atul Verma (McGill University Health Centre & McGill University, Montreal, CA, US) discuss optimal approaches to redo atrial fibrillation ablation and the critical decision of when to extend beyond… View more
Author(s): Vivek Reddy Added: 2 years ago
EHRA 24 - We interview Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, US) on a first-in-human clinical trial of a novel conformable "single-shot" pulsed field ablation (PFA) catheter for pulmonary vein isolation (PVI).This single arm trial aimed to assess the safety and efficacy of PVI using an 8Fr PFA catheter (SpherePVI, Affera Inc) in 30 patients across three centers.Interview… View more
Author(s): Marco Schiavone , Claudio Tondo Added: 3 months ago
Dr Marco Schiavone (Centro Cardiologico Monzino IRCCS, Milan, IT) and Dr Claudio Tondo (Monzino Cardiologic Centre, Milan, IT) discuss long-term durability data from an 8-year follow-up study of cryoballoon pulmonary vein isolation for atrial fibrillation.In this Journal Club session, the experts dig into real-world evidence on the extended durability of cryoballoon ablation, tackling key… View more
Author(s): Laurent Fiorina Added: 2 years ago
For short, concise coverage of the key data revealed, our accessibleExpert Interviewswere conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice. View more
Author(s): Daniel Scherr Added: 1 year ago
AF Symposium 25 - The MANIFEST-REDO sub-study suggests repeat ablation procedures due to clinical recurrence of atrial fibrillation (AF) can be performed safely and with an acceptable success rate.Prof Daniel Scherr (Medical University, Graz, AT) joins us onsite at AF Symposium 25 to discuss the insights from MANIFEST-REDO, investigating repeated ablation following pulmonary vein isolation (PVI)… View more
Author(s): Roland R Tilz Added: 2 years ago
EHRA 24 - We are joined onsite by Dr Roland Tilz (University Heart Center, DE) to discuss the findings of the Style-AF study (NCT05563142).This prospective, randomized, controlled study aims to compare the safety and efficacy of the Perclose ProStyle suture-medicated closure device to manual compression for the treatment of hemostasis after single-shot-device pulmonary vein isolation (PVI). 125… View more
Author(s): Luigi Di Biase Added: 2 years ago
EHRA 2024 — Dr Luigi Di Biase (Albert Einstein College of Medicine and Montefiore Medical Center, US) highlights 3 late-breaking trials from the 2024 EHRA scientific sessions. Discover the trials anticipated to reshape clinical practice as Dr Di Biase shares his insights.Trials discussed in detail include:00:36 - Novel Conformable "Single-Shot" PFA Catheter for Pulmonary Vein Isolation01:08 -… View more
Job title: Professor
Professor Dipen Shah is trained as an interventional cardiologist in India, then as an electrophysiology fellow in Bordeaux with Professor Haissaguerre. He spent 6 years in Bordeaux, performing clinical research related to the catheter ablation of atrial flutter, and fibrillation as well as participating in the development of pulmonary vein isolation. He joined the University Hospitals Geneva as… View more